Skip to main content
OpenTrials

Clinical trial condition

Breast Neoplasms

Explore clinical trials studying Breast Neoplasms. Study availability and eligibility vary by location and protocol.

609 public trials 216 recruiting studies
Refine in advanced search Browse all conditions

Breast Neoplasms trial results

Completed

Phase 1b Multi-indication Study of Anetumab Ravtansine in Mesothelin Expressing Advanced Solid Tumors

NCT03102320

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +28 more
Locations
  • Mayo Clinic Hospital Phoenix, Arizona, United States
  • University of Southern California Los Angeles, California, United States
  • Stanford Health Care Stanford, California, United States
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
View all 72 locations
View Trial Details
Completed

Enhance the Use of Genetic Counseling and Testing in Latinas

NCT04544501

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +20 more
Locations
  • Capital Breast Care Center Washington D.C., District of Columbia, United States
  • Nueva Vida Alexandria, Virginia, United States
  • Arlington Free Clinic Arlington, Virginia, United States
  • Virginia Commonwealth University Richmond, Virginia, United States
View Trial Details
Completed

A Study of the Safety, Tolerability and Pharmacokinetics of ABBV-368 as a Single Agent and Combination in Subjects With Locally Advanced or Metastatic Solid Tumors

NCT03071757

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +58 more
Locations
  • Moores Cancer Center at UC San Diego /ID# 201334 La Jolla, California, United States
  • University of California, Davis Comprehensive Cancer Center /ID# 201342 Sacramento, California, United States
  • Stanford University /ID# 206949 Stanford, California, United States
  • Yale University /ID# 207895 New Haven, Connecticut, United States
View all 27 locations
View Trial Details
Completed

Testing an Intelligent Tutoring System to Enhance Genetic Risk Assessment

NCT03511690

Conditions
Adnexal Diseases, Breast Diseases, Breast Neoplasms, +21 more
Locations
  • Capital Breast Care Center Washington D.C., District of Columbia, United States
  • Georgetown University Washington D.C., District of Columbia, United States
  • Nueva Vida Alexandria, Virginia, United States
  • Virginia Commonwealth University Richmond, Virginia, United States
View Trial Details
Completed

A Study of Budigalimab (ABBV-181) in Participants With Advanced Solid Tumors

NCT03000257

Conditions
Adenocarcinoma, Adenoma, Adnexal Diseases, +56 more
Locations
  • Moores Cancer Center at UC San Diego /ID# 157374 La Jolla, California, United States
  • The University of Chicago Medical Center /ID# 157375 Chicago, Illinois, United States
  • Carolina BioOncology Institute /ID# 157376 Huntersville, North Carolina, United States
  • South Texas Accelerated Research Therapeutics /ID# 157378 San Antonio, Texas, United States
View all 26 locations
View Trial Details
Completed

Study to Explore the Safety, Tolerability and Efficacy of MK-3475 in Combination With INCB024360 in Participants With Selected Cancers

NCT02178722

Conditions
Adenocarcinoma, Adnexal Diseases, Bladder Cancer, +76 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • The Angeles Clinic and Research Institute Los Angeles, California, United States
  • US Davis Cancer Center Sacramento, California, United States
  • University Of Colorado Cancer Center Aurora, Colorado, United States
View all 24 locations
View Trial Details
Completed

Safety Study of MGA271 in Refractory Cancer

NCT01391143

Conditions
Adenocarcinoma, Bladder Cancer, Breast Diseases, +49 more
Locations
  • UCLA Hematology-Oncology Clinic Los Angeles, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • The University of Chicago Chicago, Illinois, United States
View Trial Details

Related conditions